UNICA IRIS Institutional Research Information System

PANI, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 88.854
NA - Nord America 9.731
AS - Asia 4.298
SA - Sud America 1.294
Continente sconosciuto - Info sul continente non disponibili 491
AF - Africa 156
OC - Oceania 13
Totale 104.837
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 87.046
US - Stati Uniti d'America 9.435
SG - Singapore 1.722
CN - Cina 1.110
BR - Brasile 1.003
VN - Vietnam 571
SE - Svezia 498
DE - Germania 247
FR - Francia 244
FI - Finlandia 210
HK - Hong Kong 206
GB - Regno Unito 178
CA - Canada 140
UA - Ucraina 128
AR - Argentina 121
BD - Bangladesh 119
IN - India 99
KR - Corea 66
NL - Olanda 64
AT - Austria 60
MX - Messico 56
ID - Indonesia 55
MA - Marocco 47
EC - Ecuador 46
IQ - Iraq 44
JP - Giappone 35
RU - Federazione Russa 34
PK - Pakistan 33
TR - Turchia 33
ZA - Sudafrica 33
CO - Colombia 30
PH - Filippine 27
VE - Venezuela 27
PL - Polonia 25
CL - Cile 24
JM - Giamaica 23
ES - Italia 18
PY - Paraguay 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 15
EG - Egitto 14
NI - Nicaragua 14
CR - Costa Rica 12
IE - Irlanda 12
IL - Israele 12
AU - Australia 11
BE - Belgio 11
DZ - Algeria 11
HN - Honduras 11
AZ - Azerbaigian 10
JO - Giordania 10
NP - Nepal 10
TN - Tunisia 10
TW - Taiwan 10
BG - Bulgaria 9
LT - Lituania 9
PE - Perù 9
UY - Uruguay 9
IR - Iran 8
KZ - Kazakistan 8
MY - Malesia 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
ET - Etiopia 7
KE - Kenya 7
PT - Portogallo 7
SC - Seychelles 7
AL - Albania 6
BO - Bolivia 6
DK - Danimarca 6
KG - Kirghizistan 6
LV - Lettonia 6
OM - Oman 6
CW - ???statistics.table.value.countryCode.CW??? 5
GP - Guadalupe 5
GT - Guatemala 5
BH - Bahrain 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KW - Kuwait 4
LB - Libano 4
PA - Panama 4
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
GR - Grecia 3
HU - Ungheria 3
KH - Cambogia 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
BZ - Belize 2
Totale 104.315
Salva come PNG Salva come JPEG
Città #
Cagliari 82.741
Uta 3.310
Ashburn 1.301
Singapore 799
Fairfield 728
Dallas 685
San Jose 597
Boardman 394
Nyköping 335
Woodbridge 329
Seattle 300
Houston 296
Council Bluffs 271
Cambridge 265
Wilmington 243
Ho Chi Minh City 211
Los Angeles 208
Hong Kong 191
Santa Clara 188
Beijing 184
Chandler 184
Helsinki 174
Ann Arbor 146
New York 143
Lauterbourg 137
The Dalles 125
Rome 119
Shanghai 100
Jacksonville 98
São Paulo 98
Milan 95
Dearborn 93
Hanoi 87
Boston 86
Buffalo 85
Hefei 81
Nanjing 68
Dong Ket 64
Seoul 64
Phoenix 61
Chicago 50
Orem 50
Munich 49
San Diego 49
Columbus 45
Frankfurt am Main 45
London 43
Montreal 43
Nuremberg 39
Atlanta 38
Denver 34
Toronto 34
Bologna 32
Rio de Janeiro 31
Belo Horizonte 30
Princeton 29
San Francisco 29
Chennai 28
Guangzhou 28
Naples 28
Tokyo 28
Brooklyn 27
Casablanca 26
Vienna 26
North Bergen 25
Bari 23
Jiaxing 23
Hebei 22
Lappeenranta 22
Redwood City 22
Brasília 21
Nanchang 21
Redondo Beach 21
Johannesburg 20
Baghdad 19
Da Nang 19
Guayaquil 19
Warsaw 19
Haiphong 18
Sèlegas 18
Changsha 17
Dothan 16
Paris 16
Philadelphia 16
Tashkent 16
Tianjin 16
Curitiba 15
Las Vegas 15
Norwalk 15
Stockholm 15
Biên Hòa 14
Catania 14
Manchester 14
Santiago 14
Washington 14
Amsterdam 13
Buenos Aires 13
Mexico City 13
Quito 13
Sassari 13
Totale 97.169
Salva come PNG Salva come JPEG
Nome #
Overexpression of the cytokine BAFF and autoimmunity risk 4.154
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.794
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.754
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 3.004
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.933
Long-term lithium and estimated glomerular filtration rate 2.927
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.132
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 2.025
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population 1.859
Risk of adverse pregnancy outcomes in women with CKD 1.628
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 1.540
Cardiorenal syndrome type 4 (CRS 4) associated with anaemia long term survival analysis 1.515
Exercise-Associated hyponatremia: 2017 update 1.487
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 1.487
Genome-Wide Analysis Studies and Chronic Kidney Disease 1.438
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis 1.363
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up 1.362
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? 1.285
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group 1.214
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 1.204
Opening an onconephrology clinic: recommendations and basic requirements 1.192
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results 1.169
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 1.161
A multicenter study of the predictive value of crescents in IgA nephropathy 1.147
Treatment of primary membranous nephropathy: where are we now? 1.143
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment 1.141
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) 1.099
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 1.080
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group 1.064
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama 1.037
Diabetic kidney disease: A syndrome rather than a single disease 1.029
Patient Selection and Timing of Continuous Renal Replacement Therapy 1.018
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 970
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population 942
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations 920
Glomerular diseases and cancer: evaluation of underlying malignancy 889
FSGS: from pathogenesis to the histological lesion 853
Diagnosis of complement alternative pathway disorders 835
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy 828
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy 794
Sodium and Volume Disorders in Advanced Chronic Kidney Disease 792
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries 766
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity 762
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort 760
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 747
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study 719
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 713
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 709
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside 699
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 686
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 664
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy 656
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 652
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 642
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report 627
Hyperkalemia in hemodialysis patients 623
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 618
Chronic kidney disease of undetermined etiology around the world 610
Standard immunosuppressive therapy of immune-mediated glomerular diseases 599
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 591
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy 565
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 558
Tossicità renale da farmaci antineoplastici 557
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario 550
Immunosuppressive treatment in dialysis patients 548
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry 527
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study 514
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine 503
Classification and Management of MGRS Related Diseases 502
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial 496
DIAGNOSIS AND PREVALENCE OF NON DIABETIC RENAL DISEASES IN PATIENTS WITH DIABETES: A TWENTY YEARS EXPERIENCE 489
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 487
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome 484
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy 481
Transplant Candidate with Cancer: Should We Proceed? 464
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome 453
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 446
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 444
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 442
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification 442
La Nefrologia in Tasca 441
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE 435
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients 427
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 426
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 422
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 421
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 418
An Integrated Multidisciplinary Approach to the Care of Renal Cancer Patients Undergoing Nephrectomy 415
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 407
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 402
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis 401
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium 395
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study 394
The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology 392
L'utilita' delle biopsie protocollari nel trapianto di rene: pro e contro.[The usefulness of protocol biopsies after kidney transplant: pros and cons] 382
[A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)]. 377
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS 374
The role of rituximab in the treatment of ANCA-associated systemic vasculitis 367
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 352
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009 352
Totale 94.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.398 0 0 0 0 463 549 326 238 408 484 1.036 894
2022/20238.620 796 854 908 604 876 838 473 742 613 564 916 436
2023/202412.187 403 413 448 630 1.134 2.215 2.376 814 645 613 1.121 1.375
2024/202522.698 3.917 5.284 3.102 3.253 1.643 2.578 1.495 136 334 371 267 318
2025/20269.600 637 349 1.288 1.056 780 708 1.674 592 684 826 514 492
2026/20273.550 343 830 755 1.456 166 0 0 0 0 0 0 0
Totale 104.837